EAM Global Investors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-104,754
| Closed | -$1.7M | – | 188 |
|
|
2022
Q1 | $1.7M | Buy |
+104,754
| New | +$1.7M | 0.31% | 172 |
|
|
2021
Q4 | – | Sell |
-105,976
| Closed | -$1.52M | – | 202 |
|
|
2021
Q3 | $1.52M | Sell |
105,976
-51,089
| -33% | -$734K | 0.36% | 130 |
|
|
2021
Q2 | $2.48M | Buy |
+157,065
| New | +$2.48M | 0.69% | 53 |
|
|
2020
Q3 | – | Sell |
-348,249
| Closed | -$1.66M | – | 140 |
|
|
2020
Q2 | $1.66M | Buy |
+348,249
| New | +$1.66M | 0.75% | 58 |
|
|
2019
Q2 | – | Sell |
-180,199
| Closed | -$1.47M | – | 135 |
|
|
2019
Q1 | $1.47M | Hold |
180,199
| – | – | 0.65% | 77 |
|
|
2018
Q4 | $1.45M | Buy |
+180,199
| New | +$1.45M | 0.8% | 52 |
|